Kewaunee Scientific Refinances Debt to Enhance Financial Flexibility and Growth Potential

Kewaunee Scientific Strengthens Financial Position Through Strategic Refinancing

Kewaunee Scientific Corporation announces a significant financial maneuver aimed at enhancing its operational flexibility and reducing debt. On December 4, 2025, the company successfully refinances its debt obligations, including the early repayment of $23 million in Seller Notes that were initially set to mature in 2027. This strategic move is made possible through an amendment to Kewaunee's Loan Agreement with PNC Bank, which involves securing an additional $10 million term loan and utilizing its existing revolving credit line. The overall effect of this refinancing not only alleviates Kewaunee's immediate debt burden but also results in a lower effective interest rate across its debt portfolio, leading to reduced future interest expenses.

The Vice President and CFO of Kewaunee, Donald T. Gardner III, articulates that this financial restructuring reflects the company's commitment to prudent capital management. The decision is underscored by Kewaunee's robust financial performance, driven by both its legacy operations and the recent acquisition of Nu Aire, Inc. This dual focus on performance and strategic acquisition positions Kewaunee to leverage enhanced financial health for future growth initiatives. The company aims to channel the flexibility gained from this refinancing into both organic and inorganic strategies, reinforcing its commitment to delivering value to shareholders.

Kewaunee's proactive approach to financial management demonstrates a disciplined strategy in navigating the competitive landscape of laboratory and healthcare furniture manufacturing. By reducing debt and lowering interest costs, Kewaunee not only secures its current financial standing but also paves the way for sustained growth and operational stability. This strategic decision embodies the company's long-term vision, ensuring it remains a leader in designing and manufacturing innovative laboratory solutions.

In addition to these financial developments, Kewaunee continues to focus on enhancing its product offerings and expanding its market reach. As a well-established player in the industry since 1906, the company remains committed to innovation and quality, leveraging its expertise to meet the evolving needs of its clients in laboratory, healthcare, and technical sectors. The recent refinancing initiative further solidifies Kewaunee's foundation, enabling it to pursue new opportunities and strengthen its competitive edge in the marketplace.